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PURPOSE. To evaluate the association between endothelial cell density (ECD) after Descemet’s
stripping automated endothelial keratoplasty (DSAEK) and preoperative cytokine levels in the
aqueous humor (AqH).
METHODS. This prospective consecutive case series included 97 consecutive patients who
underwent DSAEK (64 eyes) or cataract surgery (33 eyes). AqH samples were collected at the
beginning of each surgery. The levels of cytokines (IL-1a, IL-1b, IL-4, IL-6, IL-8, IL-10, IL-12p70,
IL-13, IL-17A, IFN-a, IFN-c, monocyte chemotactic protein [MCP]-1, E-selectin, P-selectin, and
soluble intercellular adhesion molecule [sICAM]-1) in the AqH were measured by multiplex
beads immunoassay. The correlations between preoperative aqueous cytokine levels and the
ECD at 12 months after DSAEK were analyzed.
RESULTS. The ECD decreased from 2747 6 259 cells/mm2 in the donor graft to 1235 6 607
cells/mm2 at 12 months after DSAEK. In all subjects undergoing DSAEK, the postoperative
ECD at 12 months was significantly correlated with the preoperative levels of MCP-1 (r ¼
0.467, 95% confidence interval [CI]: 0.650 to 0.222, P ¼ 0.0003). In an analysis
excluding Fuchs endothelial corneal dystrophy (11 eyes), the ECD at 12 months after DSAEK
was significantly correlated with preoperative levels of IL-17A (r ¼ 0.635, 95% CI: 0.819
to 0.319, P ¼ 0.0004), MCP-1 (r ¼ 0.605, 95% CI: 0.779 to 0.345, P < 0.0001), IFN-c
(r ¼ 0.633, 95% CI: 0.796 to 0.385, P < 0.0001), E-selectin (r ¼ 0.516, 95% CI:
0.756 to 0.276, P ¼ 0.0004), and sICAM-1 (r ¼ 0.537, 95% CI: 0.735 to 0.253, P ¼
0.0005).
CONCLUSIONS. Higher preoperative levels of IL-17A, MCP-1, IFN-c, E-selectin, and sICAM-1 in the
AqH were associated with lower ECD after DSAEK for bullous keratopathy.
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automated endothelial keratoplasty
Descemet’s stripping automated endothelial keratoplasty(DSAEK) for the treatment of endothelial dysfunction has
several advantages over standard penetrating keratoplasty
(PKP).1–3 By removing only the Descemet’s membrane and
dysfunctional endothelium, and retaining healthy portions of
the patient’s cornea, DSAEK offers rapid visual recovery,2,3
resulting in less graft rejections than PKP and leading to a
favorable long-term graft survival rate up to 80% to 87% at 5
years.4,5 The primary cause of graft failure after DSAEK is
endothelial decompensation, even in eyes without evidence of
immunologic rejection.4–6 The endothelial cell density (ECD)
decreases with age, and in various conditions including uveitis
and postintraocular surgeries.7–10 The risk factors for endothe-
lial cell loss after DSAEK include a history of glaucoma surgery
and graft rejection.5,11–13 In contrast, the ECD prognosis is
reported to be favorable in eyes with Fuchs’ endothelial corneal
dystrophy (FECD) compared with pseudophakic bullous
keratopathy.14 However, the exact mechanism of chronic
endothelial cell loss is still poorly understood.
Recently, we reported that severe pre-existing iris damage
was one of the clinical factors for graft failure and rapid
endothelial cell loss after DSAEK.6 However, the reasons behind
decreased ECD in eyes with severe iris damage remain elusive.
Anatomically, the aqueous humor (AqH) is present between the
corneal endothelium and the iris, and it has been reported that
inflammatory cytokines in the AqH increase during various
pathological processes.15–18 In an in vitro study, a combination
of proinflammatory cytokines synergistically induced the
apoptosis of corneal endothelial cells.19 We recently showed
that inflammatory cytokine levels were elevated in the AqH of
eyes with bullous keratopathy and reduced ECDs,20 and that
iris damage was associated with an elevation in aqueous
cytokine levels.21 Collectively, these results suggest that
inflammatory factors in the AqH directly influence endothelial
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cell loss. However, an elevation in aqueous cytokine levels can
just be the result, not the direct cause, following endothelial
cell loss. Thus, we hypothesized that the AqH conditions, such
as elevated cytokine levels, can cause rapid loss of ECD after
corneal transplantation. In our latest study, we showed that
higher preoperative aqueous levels of specific cytokines were
associated with rapid ECD loss after PKP.22 The purpose of this
study is to evaluate the association between preoperative
cytokine levels in the AqH and reduction of ECD following
DSAEK.
METHODS
This prospective study was performed in accordance with the
Declaration of Helsinki. The Institutional Ethics Review Board
of Tokyo Dental College, Ichikawa General Hospital (I-15-42R),
approved it. Written informed consent was obtained from all
participants prior to the interventions.
Study Participants
A total of 97 consecutive patients who underwent DSAEK
(DSAEK group, 64 eyes) and cataract surgery (control group,
33 eyes) at Ichikawa General Hospital, Tokyo Dental College,
from October 26, 2015 to August 10, 2016 were included
(Table 1). We excluded eyes with active inflammation of the
cornea or the anterior chamber and patients systemically
administered steroids from the study. The etiologies of DSAEK
in the studied eyes included pseudophakic bullous keratopathy
(25 eyes), postlaser iridotomy bullous keratopathy (11 eyes),
FECD (11 eyes), posttrabeculectomy bullous keratopathy (10
eyes), uveitis (4 eyes), birth injury (2 eyes), and unknown
cause (1 eye). We performed solitary DSAEK in 43 eyes and
DSAEK combined with simultaneous cataract surgery in 21
eyes. Control participants were defined as patients who
underwent cataract surgery without uveitis or systemic
inflammatory diseases, such as ulcerative colitis or rheumatoid
arthritis, and had not undergone corneal or intraocular
surgeries previously. All participants in the control group had
an ECD exceeding 2000 cells/mm2.
Surgical Technique
DSAEK surgery was performed using double-glide tech-
nique.23,24 All DSAEK surgeries were performed by one of
three experienced surgeons (TY, YS, or JS). After sub-Tenon
anesthesia with injection of 2% lidocaine, a 5.0-mm temporal
corneoscleral incision was made. An anterior chamber
maintenance cannula was inserted through the 2 or 10 o’clock
paracentesis, and Descemet stripping was performed with a
reverse-bent Sinsky hook (Asico, Westmont, IL, USA). The
recipient’s endothelium and Descemet’s membrane were
carefully removed using forceps. Precut donor grafts were
trephinated and the endothelial surface of the donor lenticle
was coated with a small amount of viscoelastic material. Donor
tissue was gently inserted into the anterior chamber using a
Busin glide (Asico) and Shimazaki DSAEK forceps (Inami,
Tokyo, Japan). Air was carefully injected into the anterior
chamber to unfold the graft. At 10 minutes after air injection,
half of the air was replaced by balanced salt solution (BSS;
Alcon, Fort Worth, TX, USA). At the end of the surgery, 2-mg
subconjunctival betamethasone was administered. In patients
with significant lens opacity (21 eyes), standard phacoemulsi-
fication, and aspiration were performed with implantation of
an IOL, followed by the DSAEK procedure. All DSAEK
procedures were successful and uneventful, without any
excessive intraoperative manipulation. In 5 eyes, early postop-
erative double chamber necessitated air injection and resolved
without any serious complications. We excluded these eyes
from the correlation analyses, because air injection is
associated with ECD loss after DSAEK.5,6,25 One patients had
mild IOP elevation up to 22 mm Hg, which resolved with a
topical antiglaucoma agent. There was no case with graft
rejection up to the 12-month follow-up. Patients were
prescribed topical eyedrops levofloxacin (Cravit; Santen,
Osaka, Japan) and betamethasone 0.1% eyedrops (Sanbetazon;
Santen) five times a day. Topical betamethasone eyedrops were
tapered over the following 6 months. Starting from 6 months
after DSAEK, we prescribed fluorometholone 0.1% eyedrops
(Flumetholone 0.1; Santen) three times a day for up to 12
months after surgery.
Aqueous Humor Samples
The AqH samples containing 70 to 300 lL were obtained under
sterile conditions at the beginning of surgery after topical
anesthesia in DSAEK and cataract surgery. First, paracentesis
was placed at the clear cornea. AqH sample was obtained using
a 27-G needle taking care not to touch the iris, the lens, or
corneal endothelium. The samples were centrifuged at 3000g
for 5 minutes. The soluble factions were collected and stored at
808C until measurements.
Protein and Cytokine Level Measurements
The protein concentrations of AqH samples were determined
using the DC protein assay (Bio-Rad, Hercules, CA, USA).20 In
brief, bovine serum albumin (BSA) was used as a standard in
the range of 0.23 to 1.37 mg/mL. Samples (5 lL) of BSA and
AqH were added to 96-well microplates, followed by immedi-
ate addition of a mixture containing 25 lL reagent A and 200
lL reagent C. After 15 minutes of incubation at room
temperature in the dark, the microplates were read at 690
and 405 nm using a microplate reader (Model 550; Bio-Rad).
The cytokine levels of IL-1a, IL-1b, IL-4, IL-6, IL-8, IL-10, IL-
12p70, IL-13, IL-17A, IFN-a, IFN-c, monocyte chemotactic
protein [MCP]-1, TNF-a, E-selectin, P-selectin, soluble intercel-
lular adhesion molecule [sICAM]-1, macrophage inflammatory
protein [MIP]-1a, MIP-1b, and interferon gamma-induced
protein [IP]-10 in AqH samples were measured using Luminex
TABLE 1. Preoperative Demographics of Patients
DSAEK
Group Control
P
Value
Eyes, n 64 33
Sex, n (%)
Male 23 (36.0) 16 (48.5) 0.23*
Female 41 (64.0) 17 (51.5)
Age, y 74.3 6 9.3 75.9 6 7.6 0.47
BCVA, logMAR 1.29 6 0.74 0.38 6 0.36 <0.001
IOP, mm Hg 12.4 6 4.1 14.3 6 2.6 0.04
Axial length, mm 23.63 6 2.08 23.84 6 1.58 0.58
ECD, cells/mm2 422 6 54 2760 6 343 <0.001
CCT, lm 741 6 111 534 6 19 <0.001
DM, n (%) 10 (16) 1 (3) 0.06*
Presence of glaucoma, n (%) 17 (27) 0 (0) 0.001*
IOL, n (%) 43 (67) 0 (0) <0.001*
Previous intraocular
surgeries, n
1.6 6 1.5 0.0 6 0.0 <0.001
Mean 6 SD. BCVA, best-corrected visual acuity; AL, axial length;
CCT, central corneal thickness; DM, diabetes mellitus; NA, not
available; SD, standard deviation.
* v2 test.
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(ProcaPlex kit; Luminex, San Antonio, TX, USA) beads-based
multiplex immunoassay according to previous reports.26
Briefly, 50 lL of AqH samples were incubated with antibody-
coated capture beads in an incubation buffer at room
temperature. After 2-hour incubation, the beads were washed
three times using washing buffer, and phycoerythrin-labeled
streptavidin was added for 30 minutes in the dark at room
temperature. After being washed three times with washing
buffer, plates were resuspended in 150 lL of reading buffer,
and the assays were performed using a Luminex 200.
Data Analysis
Routine examinations, including slit-lamp evaluation, best
spectacle-corrected distance visual acuity, IOP, and ECD, were
performed preoperatively and at 1, 3, 6, and 12 months after
surgery. The ECD was measured by masked orthoptists using a
specular microscopy system (EM-4000; TOMEY, Nagoya,
Japan). Approximately, 50 cells were analyzed for mean cell
density. ECD was determined by the automated software of EM-
4000. In eyes in which the automated cell counts failed or
misidentified endothelial cells, ECD was determined using the
center method for manual counting. We analyzed ECD as
absolute ECD and percentage ECD loss (%ECD loss) to assess
the correlation with preoperative cytokine levels. Percent ECD
loss was defined as follows: %ECD loss ¼ ([graft ECD 
postoperative ECD] / graft ECD] 3 100. There were eight
patients with graft failure within 1 year after DSAEK (primary
graft failure in four eyes, graft failure at 3 months in 2 eyes and
at 6 months in 2 eyes). We defined the ECD as 300 cells/mm2
as previously reported,6 because the ECD could not be directly
measured due to corneal edema. At 1 and 3 months, ECD
measurement was difficult in some patients due to residual
corneal edema or interface irregularity. As a result, the number
of eyes with successful ECD measurements at 1, 3, 6, and 12
months following DSAEK were 49, 58, 58, and 56, respectively.
We classified patients into two groups based on the ECD at 12
months after DSAEK: one group included eyes where the ECD
was more than 1200 cells/mm2 and the other group included
eyes where the ECD was less than 1200 cells/mm2 at 12
months. The cut-off value of 1200 was set following our
previous study.22
Statistical Analysis
Data were analyzed using Prism for Windows software (version
6.04; Graphpad Software, Inc., La Jolla, CA, USA). The
D’Agostino & Pearson omnibus normality test was used to
assess whether the data showed a normal distribution. Spear-
man’s correlation analyses were used to evaluate the correla-
tions among AqH cytokine levels and ECD. From the
correlation analyses, we excluded five eyes in which air
injection was performed for the treatment of postoperative
double chamber, because air injection is associated with the
ECD loss after DSAEK.5,6,25 To assess the differences in the time
courses of decreases in postoperative ECD between the ECD
‡1200 and the ECD <1200 groups, a one-way ANOVA was
used. To compare the differences in protein and cytokine
levels across the groups, the Mann-Whitney U test was used.
For multivariate analyses, we used STATA/IC 14.0 for Windows
(StataCorp LP, College Station, TX, USA). To assess the clinical
factors that can be correlated with the postoperative ECD, we
selected five clinical factors (graft size, the presence of
glaucoma, preoperative steroid use, history of laser iridotomy
[LI]/trabeculectomy, and the lens status) and conducted
multiple linear regression analyses. The presence of glaucoma,
preoperative steroid use, history of LI/trabeculectomy, and the
lens status were dichotomized as independent variables
(variance inflation factors [VIF] ¼ 1.14–1.16). The data are
expressed as means 6 standard deviation (SD). P values < 0.05
were considered to be statistically significant except cytokine
data. Cytokine data were also controlled with Bonferroni
correction. Because there were 20 different comparisons (1
protein and 19 cytokines), P values < 0.0025 (i.e., P¼0.05/20)
were considered to be statistically significant after Bonferroni
correction.
RESULTS
Pre- and Postoperative ECD
In the 64 eyes that underwent DSAEK, the ECD was 2747 6
259 cells/mm2 in the donor graft, 1815 6 592 cells/mm2 at 1
month, 1470 6 623 cells/mm2 at 3 months, 1294 6 600 cells/
mm2 at 6 months, and 1235 6 607 cells/mm2 at 12 months
after DSAEK. There were significant correlations among the
postoperative ECD at 3, 6, and 12 months (Supplementary
Table S1). Between the two groups (ECD ‡1200 group and
ECD <1200 group), there were no significant differences in
age (72.4 6 10.8 and 74.5 6 8.5 years, respectively; P¼ 0.90)
and graft ECD (2774 6 179 and 2700 6 327 cells/mm2,
respectively; P ¼ 0.49). There were significant differences in
ECD at 1, 3, 6, and 12 months after DSAEK between the two
groups (Supplementary Fig. S1, P¼ 0.02, P¼ 0.01, P < 0.001,
and P < 0.001, respectively).
Preoperative Protein and Cytokine Levels in
Aqueous Humor
The preoperative levels of AqH protein, IL-6, IL-8, IL-10, IL-
12p70, IL-17A, MCP-1, IFN-c, E-selectin, P-selectin, and sICAM-
1 were significantly higher in eyes undergoing DSAEK
compared with the control group (Table 2, all P  0.0018).
In the ECD ‡1200 group, the levels of IL-6, IL-10, E-selectin,
and P-selectin were significantly higher compared with those
of the control group (Supplementary Table S2, all P  0.0025).
In the ECD <1200 group, the levels of protein, IL-4, IL-6, IL-
TABLE 2. Preoperative Aqueous Cytokine Levels
DSAEK (N ¼ 64) Control (N ¼ 33) P Value*
Protein 1.25 6 0.13 (1.18) 0.31 6 0.40 (0.25) <0.0001
IL-1a 69.3 6 14.8 (55.9) 49.3 6 4.4 (44.2) 0.046
IL-1b 5.2 6 1.7 (1.8) 3.1 6 1.7 (1.1) 0.128
IL-4 45.0 6 6.5 (29.8) 20.5 6 1.0 (20.8) 0.005
IL-6 1668 6 450 (426) 85 6 69 (5.1) <0.0001
IL-8 93.7 6 18.2 (49.8) 46.4 6 25.3 (21.4) <0.0001
IL-10 10.6 6 4.2 (3.3) 1.9 6 0.1 (1.7) <0.0001
IL-12p70 12.9 6 1.7 (8.6) 6.4 6 0.2 (6.4) <0.0001
IL-13 9.5 6 0.9 (9.2) 7.1 6 0.2 (7.1) 0.0047
IL-17A 10.3 6 1.6 (7.2) 4.0 6 0.4 (3.5) <0.0001
MIP-1a 14.7 6 3.2 (11.2) 9.4 6 0.4 (8.7) 0.335
MIP-1b 345 6 79.1 (226) 345 6 20.3 (321) 0.100
MCP-1 1022 6 111 (720) 592 6 84.4 (470) 0.0005
TNF-a 162 6 178 (97.2) 76.4 6 5.4 (70.2) 0.0116
IFN-a 4.8 6 0.6 (4.2) 4.1 6 0.1 (3.9) 0.520
IFN -c 106.3 6 15.8 (70.3) 55.6 6 2.1 (54.6) 0.0018
E-selectin 4170 6 640 (3104) 2149 6 46.0 (2145) <0.0001
P-selectin 11323 6 2242 (7431) 3724 6 131 (3581) <0.0001
sICAM-1 5971 6 882 (3966) 2027 6 450 (1304) <0.0001
IP10 295 6 319 (157) 257 6 89.4 (98.3) 0.0251
Mean 6 SE (Median); Protein:(mg/mL); Cytokines:(pg/mL). Statis-
tically significant values are in bold.
* Mann-Whitney U test. SE, standard error.
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12p70, IL-17A, IFN-c, E-selectin, P-selectin, and sICAM-1 were
significantly higher compared with those of the control group
(all, P  0.0025). Although there were no statistically
significant differences, the levels of MCP-1 and IFN-c were
higher in the ECD <1200 group compared with the ECD
‡1200 group (P ¼ 0.01 and P ¼ 0.02, respectively).
Correlations Between Preoperative Aqueous
Cytokine Levels and Postoperative ECD
Table 3 shows the correlations between preoperative aqueous
cytokine levels and absolute ECDs at 6 and 12 months after
DSAEK in all subjects. The ECD at 12 months was inversely
correlated with the levels of MCP-1 (r ¼ 0.467, 95%
confidence interval [CI]: 0.650 to 0.222, P ¼ 0.0003). The
%ECD loss at 12 months was inversely correlated with the
levels of MCP-1 (Supplementary Table S4, r ¼ 0.470, 95% CI:
0.232–0.656, P ¼ 0.0002). In contrast, all of the preoperative
cytokine levels were not correlated with ECD and %ECD loss at
6 months after cataract surgery (Supplementary Table S5).
Associations Between Endothelial Cell Density and
Presence of Glaucoma
Lens status, history of LI and presence of glaucoma have been
reported to be factors related to ECD reduction.5,8,9,27 To
evaluate the association between ECD and these factors, we
conducted multivariate regression analyses in which the
presence of glaucoma, history of LI, graft size, preoperative
steroid use, and lens status were included as independent
variables (Table 4). The presence of glaucoma was significantly
associated with lower ECD (b¼0.321, P¼ 0.024 at 3 months,
b¼0.339, P¼ 0.009 at 6 months and b¼0.317, P¼ 0.010 at
12 months). History of LI was associated with lower ECD (b¼
0.257, P¼ 0.046 at 6 months, and b¼0.333, P¼ 0.008 at 12
months). History of trabeculectomy was associated with lower
ECD after DSAEK (b ¼ 0.352, P ¼ 0.011 at 3 months, b ¼
0.287, P¼ 0.028 at 6 months, and b¼0.278, P¼ 0.026 at 12
months; Supplementary Table S6).
Correlations Between Preoperative Aqueous
Cytokine Levels and Postoperative ECD in Subjects
Excluding Fuchs Endothelial Corneal Dystrophy
A limitation of this study is the heterogeneity in the causative
diseases. Then, we conducted correlation analyses between
preoperative aqueous cytokine levels and postoperative ECD
excluding the eyes with FECD (Table 5; Supplementary Table
S7). The ECDs were inversely correlated with the levels of IL-
17A (r¼0.652, P ¼ 0.0002 at 6 months and r ¼0.631, P ¼
0.0004 at 12 months), MCP-1 (r ¼0.605, P < 0.0001 at 12
months), IFN-c (r ¼0.528, P ¼ 0.0008 at 6 months and r ¼
0.633, P < 0.0001 at 12 months), E-selectin (r¼0.588, P <
0.0003 at 6 months and r¼0.516, P¼ 0.0004 at 12 months),
and sICAM-1 (r¼0.537, P¼ 0.0005 at 12 months). The %ECD
loss was correlated with the levels of IL-17A, MCP-1, IFN-c, E-
TABLE 3. Correlations Between Preoperative Cytokine Levels and Endothelial Cell Density After Descemet’s Automated Stripping Endothelial
Keratoplasty (N¼ 64)
ECD at 6 mo ECD at 12 mo
r P Value 95% CI r P Value 95% CI
Protein 0.275 0.068 0.532 to 0.029 0.256 0.086 0.515 to 0.046
IL-1a 0.248 0.092 0.051 to 0.506 0.159 0.292 0.146 to 0.437
IL-1b 0.128 0.396 0.411 to 0.177 0.037 0.810 0.335 to 0.268
IL-4 0.109 0.408 0.360 to 0.157 0.287 0.032 0.517 to 0.018
IL-6 0.008 0.995 0.258 to 0.260 0.039 0.769 0.304 to 0.231
IL-8 0.008 0.995 0.266 to 0.252 0.090 0.505 0.350 to 0.182
IL-10 0.095 0.470 0.170 to 0.348 0.016 0.907 0.255 to 0.285
IL-12p70 0.125 0.349 0.378 to 0.145 0.297 0.031 0.527 to 0.020
IL-13 0.051 0.763 0.373 to 0.283 0.106 0.539 0.428 to 0.240
IL-17A 0.399 0.0088 0.633 to 0.100 0.389 0.011 0.625 to 0.087
MIP-1a 0.248 0.118 0.074 to 0.523 0.226 0.154 0.098 to 0.512
MIP-1b 0.237 0.075 0.033 to 0.475 0.145 0.302 0.139 to 0.406
MCP-1 0.320 0.018 0.545 to 0.052 0.467 0.0003 0.650 to 0.222
TNF-a 0.177 0.261 0.143 to 0.464 0.240 0.131 0.082 to 0.517
IFN-a 0.245 0.128 0.082 to 0.524 0.144 0.381 0.189 to 0.447
IFN-c 0.317 0.018 0.543 to 0.100 0.387 0.0029 0.593 to 0.133
E-selectin 0.336 0.017 0.567 to 0.055 0.336 0.045 0.519 to 0.001
P-selectin 0.275 0.042 0.510 to 0.003 0.275 0.042 0.510 to 0.003
sICAM-1 0.351 0.0086 0.569 to 0.009 0.355 0.0067 0.569 to 0.0096
IP10 0.110 0.497 0.153 to 0.359 0.067 0.618 0.204 to 0.329
Statistically significant values are in bold.
TABLE 4. Multivariate Analysis: Presence of Glaucoma Was Associated
With Postoperative Endothelial Cell Density
ECD at 3 mo ECD at 6 mo ECD at 12 mo
b P Value b P Value b P Value
Glaucoma 0.321 0.024 0.339 0.009 0.317 0.010
Laser iridotomy 0.074 0.588 0.257 0.046 0.333 0.008
Lens status 0.089 0.531 0.068 0.597 0.197 0.113
Graft size 0.086 0.516 0.135 0.270 0.185 0.112
Prerogative
steroid use
0.044 0.752 0.064 0.626 0.032 0.801
Adjusted R2 0.075 0.169 0.361
Presence of glaucoma, laser iridotomy and lens status were
dichotomized as categoric variables for multivariate regression analysis
as follows: presence of glaucoma: absence ¼ 0, presence ¼ 1, laser
iridotomy: absence ¼ 0, presence ¼ 1, lens status: phakia ¼ 0,
pseudophakia¼1. VIF¼1.16. Statistically significant values are in bold.
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selectin, and sICAM-1 (Supplementary Table S7, P < 0.0025),
which is similar to the results we obtained for the absolute
ECD values.
Influence of Simultaneous Cataract Surgery on
Postoperative Endothelial Cell Density
Regarding the influence of simultaneous cataract surgery, we
compared postoperative ECD between solitary DSAEK (43
eyes) and DSAEK combined with simultaneous cataract surgery
(21eyes; Supplementary Table S8), which showed no signifi-
cant difference between them at any point (Supplementary Fig.
S2; Mann-Whitney U test, all P > 0.05).
Correlations Among the Preoperative Aqueous
Protein and Cytokine Levels and Endothelial Cell
Density
The Figure shows the correlations among aqueous protein and
cytokine levels in eyes that underwent DSAEK. All correlation
coefficients were positive. The red lines represent strong
positive correlations (P < 0.0001) and the blue lines represent
moderate positive correlations (P < 0.0025). The color
gradations of the circles represent the differences in cytokine
levels among healthy eyes, eyes with low postoperative ECDs
(<1200 cells/mm2) and eyes with high postoperative ECDs
(‡1200 cells/mm2). The levels of IL-17A, MCP-1, IFN-c, E-
selectin, and sICAM-1 (shown in green circles), were associ-
ated with ECD at 12 months after DSAEK.
DISCUSSION
Late endothelial dysfunction is the major cause of visual loss
after DSAEK.5,28 The average annual reduction rate of ECD has
been reported to be 0.6% in healthy eyes,29 2.5% after cataract
surgery,9 and 2.6% to 7.8% after PKP.30 Recent studies reported
that the 10-year ECD correlated with the 6-month ECD after
DSAEK and PKP, whereas it did not correlate with the baseline
donor ECD.14,31,32 Regarding the eyes after PKP, the risk factors
for endothelial cell loss after corneal transplantation include
donor and recipient ages, graft diameter, lens status, glaucoma,
and graft rejection.32–34 In contrast, regarding DSAEK, the risk
factors for the late endothelial cell loss include history of
glaucoma surgery, small diameter of graft, and severe iris
damage.5,6,11–13 However, the exact mechanism for the
reduction of ECD is still poorly understood.
AqH has a unique composition that includes proteins,
ascorbate, glutathione, and other biologically active substanc-
es. In recent years, elevated levels of cytokines in the AqH have
been reported to be associated with pathogenesis in various
ocular diseases, such as FECD,35 glaucoma,17,18,36 ocular
surface diseases,37 and graft rejection.38,39 We reported an
elevation of inflammatory cytokines in eyes with bullous
keratopathy.20 Moreover, the iris damage was associated with
the elevation of aqueous cytokine levels.21 However, these
recent reports were cross-sectional studies and the elevated
cytokine levels might just be the results, not the cause, of
endothelial cell loss. Thus, we conducted this prospective
study to assess the association of preoperative cytokine levels
and postoperative ECD after corneal transplantation.
Regarding the association between preoperative cytokine
levels and ECD after PKP, we showed that the preoperative
levels of specific aqueous cytokines, such as IL-10, MCP-1, and
IFN-c, were inversely correlated with ECD at 3 and 6 months
after PKP.22 After DSAEK, the preoperative levels of MCP-1,
IFN-c, IL-17A, E-selectin, and sICAM-1 were correlated with
postoperative ECD in eyes with pseudophakic bullous
keratopathy. MCP-1 is the main chemotactic factor for the
migration of monocytes/macrophages and the pathogenesis of
chronic inflammation.40 MCP-1 directly enhances the produc-
tion of inflammatory cytokines41 and causes cell apoptosis via
MCP-induced protein.42 IFN-c activates the immune cells and
upregulates major histocompatibility complex (MHC) class I
and II molecules.19 IFN-c induces apoptosis of endothelial cells
in vitro.19 Recently, Chen et al.43 reported that IL-17Aþ Th17
cells produce IFN-c and mediate ocular surface autoimmunity.
ICAM-1 mediates the recruitment of immune cells to sites of
TABLE 5. Correlation Between Preoperative Cytokine Levels and Endothelial Cell Density After DSAEK in Eyes Excluding Fuchs’ Endothelial
Corneal Dystrophy
ECD at 6 mo ECD at 12 mo
r P Value 95% CI r P Value 95% CI
Protein 0.262 0.170 0.581 to þ0.127 0.099 0.624 0.471 to 0.303
IL-1a 0.292 0.124 0.094 to 0.602 0.290 0.135 0.105 to 0.605
IL-1b 0.207 0.320 0.565 to 0.216 0.043 0.844 0.449 to 0.378
IL-4 0.346 0.039 0.612 to 0.010 0.439 0.0065 0.674 to 0.125
IL-6 0.080 0.648 0.270 to 0.569 0.070 0.699 0.290 to 0.412
IL-8 0.020 0.909 0.324 to 0.360 0.081 0.654 0.280 to 0.422
IL-10 0.078 0.662 0.277 to 0.414 0.121 0.507 0.248 to 0.459
IL-12p70 0.368 0.032 0.635 to 0.024 0.430 0.010 0.673 to 0.102
IL-13 0.243 0.276 0.611 to 0.212 0.220 0.351 0.612 to 0.260
IL-17A 0.652 0.0002 0.831 to 0.352 0.631 0.0004 0.819 to 0.319
MIP-1a 0.356 0.081 0.058 to þ0.665 0.482 0.017 0.085 to 0.747
MIP-1b 0.365 0.034 0.021 to 0.632 0.266 0.141 0.102 to 0.570
MCP-1 0.452 0.0050 0.682 to 0.140 0.605 <0.0001 0.779 to 0.345
TNF-a 0.194 0.341 0.220 to 0.550 0.335 0.102 0.082 to 0.652
IFN-a 0.360 0.091 0.074 to 0.680 0.314 0.152 0.137 to 0.657
IFN-c 0.528 0.0008 0.732 to 0.236 0.633 <0.0001 0.796 to 0.385
E-selectin 0.588 <0.0001 0.802 to 0.372 0.516 0.0004 0.756 to 0.276
P-selectin 0.263 0.127 0.555 to 0.083 0.163 0.366 0.487 to 0.202
sICAM-1 0.481 0.0026 0.702 to 0.177 0.537 0.0005 0.735 to 0.253
IP10 0.281 0.101 0.067 to þ0.569 0.306 0.083 0.052 to 0.595
Statistically significant values are in bold.
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inflammation,44 and its soluble form, sICAM-1 has been shown
to be increased in the AqH of patients with bullous
keratopathy.20,45 Richer et al.44 reported strong correlations
between sICAM-1 and soluble apoptotic factors, such as
soluble Fas and Fas ligand in rhegmatogenous retinal detach-
ment. Recently, Dohlman et al.46 found that blockade of E-
selectin suppressed graft rejection in murine corneal trans-
plantation model, whereas both levels of E-selectin and P-
selectin were upregulated in the rejected graft. Although there
were no eyes with graft rejection after DSAEK in the case
series, future studies on the immunologic mechanism of ECD
loss after DSAEK will be valuable.
The preoperative levels of IL-4, IL-6, IL-8, IL-10, IL-12p70,
and P-selectin were elevated in the eyes that underwent
DSAEK compared with control eyes, although there were no
correlations between the preoperative levels of these cytokines
and ECD after DSAEK. Thus, given that the combination of
cytokines synergistically induces apoptosis of endothelial
cells,19 not only MCP-1, IFN-c, and sICAM-1 but also other
cytokines may have affected ECD after DSAEK. The Figure
shows the preoperative protein and cytokine levels, as well as
the correlations among them and ECD at 12 months. There
were complicated correlations among the cytokines; the
correlations among IL-17A, MCP-1, IFN-c, E-selectin, and
sICAM-1 seem to be important, as the levels were strongly
correlated with those of other cytokines and ECD at 12 months
after DSAEK.
Regarding cytokine levels in other organ transplants,
previous reports showed the association between the serum
cytokine levels and prognosis. Allen et al.47 reported that a
preoperative inflammatory state in the recipient, as indicated
by high levels of serum IL-10 and MCP-1 has an important
impact for early lung allograft function. Kim et al.48 showed an
association of combined detection of serum IL-10, IL-17, and IP-
10 with acute rejection following adult liver transplantation.
Crescioli et al.49 reported that pretransplant serum CXCL10
can be a predictive marker for cardiac acute rejection. As in the
other organ transplants, it can be potentially valuable to
examine preoperative cytokine levels prior to corneal trans-
plantation as predictive biomarkers to prevent and treat the
chronic loss of ECD after DSAEK.
The aqueous protein levels in eyes undergoing DSAEK
were significantly higher than those in the healthy control
group, which reflects the breakdown of the blood–aqueous
barrier (BAB). Ambrose et al.50 measured aqueous flare using
a fluorophotometer, and reported that the breakdown of BAB
due to iris chafing by anterior chamber IOL influences the
progression of endothelial cell loss. The breakdown of BAB
can induce not only elevated cytokine levels, but also
extensive alterations in the other kinds of proteins in the
AqH. In the current study, a history of glaucoma and
trabeculectomy was shown to be a risk factor for low ECD,
however, there were no significant differences in cytokine
levels between DSAEK eyes with and those without history of
glaucoma or trabeculectomy. This may be attributable to the
limited number of subjects with glaucoma in the present
study, because the aqueous levels of IL-1a, IL-4, IL-8, IL-10,
IFN-c, and MCP-1 elevate in eyes after trabeculectomy.20,36
Further studies are necessary to elucidate the exact mecha-
nism of endothelial cell loss after corneal transplantation,
using proteomics analysis of the aqueous humor to specify
the alteration of the aqueous environment.
The ECD count can cause measurement error. We used the
EM-4000 automated software for ECD in the current study.
Price et al.28 reported ECD was most accurate even in DSAEK
eyes when they were measured using EM-3000, whereas ECD
differed by more than 1000 cells/mm2 when measured with
other type of specular microscope. Using Bland-Altman plots
analysis, Luft et al.51 compared four specular microscopes in
healthy eyes and eyes after DSAEK, which showed that EM-
3000 automated software (a former type of specular micro-
scope from Tomey) provided quantitative endothelial measure-
ments that were well comparable to those obtained with the
manual gold standard method even in post-DSAEK eyes.
The survival rate at 12 months was 87.5% (56/64 eyes),
which is low compared with that reported in the previous
studies.4,5 This study included complicated eyes with a history
of multiple intraocular surgeries and trabeculectomy. Stratify-
ing the subjects based on the etiologies, the survival rate at 12
months was 100% (11/11) in eye with FECD, 90.9% (10/11) in
post-LI eyes, 92% (23/25) in eyes with pseudophakic bullous
keratopathy, and 50% (5/10) in eyes after trabeculectomy,
FIGURE. Correlation among aqueous protein and cytokine levels in eyes undergoing Descemet stripping automated endothelial keratoplasty.
Preoperative aqueous cytokine levels were correlated with each other in eyes that underwent Descemet stripping automated endothelial
keratoplasty (DSAEK). The red thick lines and blue thin lines represent strong (P < 0.0001) and moderate (P < 0.0025) correlations, respectively.
All correlations were positive. The color of the circles represents the protein/cytokine levels compared with those in healthy eyes. The color
gradation of the circles represents the differences in cytokine levels among healthy eyes, eyes with low ECD (<1200 cells /mm2 at 12 months after
DSAEK) and high ECD (‡1200 cells /mm2). The cytokines associated with post-DSAEK ECD are denoted by green circles. It is noteworthy that some
cytokines (MCP-1 and IFN-c) that significantly correlated with post-DSAEK ECD are denoted by green circles with color gradients.
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which was comparable to that reported in previous stud-
ies.4,5,11,12 Thus, we postulated that the ECD reduction can be
due to inflammatory alteration of the AqH microenvironment,
not due to surgical mal-manipulation or measurement error.
Multivariate analyses showed that preoperative steroid use
was not correlated with postoperative ECD, which is
consistent with the results reported in our previous studies,
in which we showed that there were no significant differences
in cytokine levels between patients who used and did not use
topical steroids preoperatively.20–22 Therefore, the translational
impact of the current study into clinical practice may be poor.
Moreover, the current study might have been biased in that
patients with severe conditions used steroid eye drops,
whereas some of the patients with mild bullous keratopathy
did not. Thus, a prospective study will be required to evaluate
the efficacy of topical steroid in reducing preoperative aqueous
cytokine levels, which in turn may prevent ECD loss after
DSAEK. Further, the detailed response of endothelial cell
against the chronic inflammatory condition remains elusive.
What types of pathways are activated inside corneal endothe-
lial cells in inflamed AqH, ‘‘oxidative stress,’’52,53 ‘‘mitochon-
drial damage,’’54 ‘‘ER stress,’’55 or ‘‘cell senescence?’’56,57 If we
uncover the abnormal cell responses against inflamed AqH, it
could lead to prophylactic therapy. Transcriptomic analyses of
human endothelial cells derived from inflamed AqH using
microarray or next generation sequencing could specify the
implicated pathway in the future.
This study had some limitations. First, the different graft
sizes (7.5–8.5 mm) may have had some effect on the ECD
results.6 A larger graft size can cause a more severe
immunologic reaction after DSAEK because it loads more
antigen. Multivariate analyses showed that the correlation
coefficients between graft size and postoperative ECD were
positive at multiple time points (i.e., Table 4: b ¼ 0.185, P ¼
0.122, Supplementary Table S6: b ¼ 0.192, P ¼ 0.105 at 12
months), suggesting that the larger the graft size, the more ECD
after DSAEK, though there were no significant correlations.
Thus, we think its influence is minimal. Second, postoperative
inflammation due to immune response against the donor
stromal tissue or surgical trauma can increase the cytokine
levels in the AqH, which may affect ECD after DSAEK. In the
future, we will have to evaluate the correlations between pre-
and postoperative cytokine levels after obtaining the approval
from our institutional review board. This study will show the
direct correlations between postoperative cytokine levels and
ECD after DSAEK. Third, the nature of the underlying disease
was heterogeneous in the current study. The analyses
excluding FECD eyes showed stronger correlations between
preoperative cytokines and ECD after DSAEK, suggesting that
the mechanism involved in ECD reduction in pseudophakic
bullous keratopathy may be different from that in FECD.
Another limitation is the statistical analyses we performed. In
the current study, due to the limited number of subjects, we
used Spearman correlation analyses at 6 and 12 months.
However, to evaluate the correlation between ECD and the
clinical/AqH factors comprehensively as previously report-
ed,34,58 longitudinal repeated measures analyses are more
appropriate. We will increase the number of subjects and
conduct longitudinal repeated measures analyses in the future.
In conclusion, we showed that the preoperative levels of
specific aqueous cytokines, such as MCP-1, IFN-c, IL-17A, E-
selectin, and sICAM-1, had a significant correlation with ECD
after DSAEK for bullous keratopathy.
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 Supplementary Figure 1 
 
 
 
 
 
Supplementary Figure 2 
Supplementary table 1. Correlation of endothelial cell density among graft, 3, 6, 
and 12 months after Descemet’s automated stripping endothelial keratoplasty. 
 
Graft 3 months 6 months 12 months 
Graft  
<0.001 
(0.999) 
0.091 
(0.483) 
0.050 
(0.698) 
3 months 
<0.001 
(0.999) 
 
0.859 
(<0.001) 
0.723 
(<0.001) 
6 months 
0.091 
(0.483) 
0.859 
(<0.001) 
 
0.898 
(<0.001) 
12 months 
0.050 
(0.698) 
0.723 
(<0.001) 
0.898 
(<0.001)  
Correlation coefficient*  
(P value)  
*Spearman correlation analysis 
  
Supplementary table 2. Preoperative aqueous cytokine levels stratified by 
endothelial cell density of 1,200 cells/mm2 at 12 months after Descemet’s 
automated stripping endothelial keratoplasty. 
 
Control (N=33) ECD ≥1200 (N=35) ECD < 1200 (N=29) P value† P value‡ P value¶ P value* 
Protein 0.31 ± 0.23 0.94± 0.84 1.31 ± 0.79 0.003 <0.001 0.18 <0.001 
IL-1α 49.3 ± 25.5 68.7 ± 48.1 99.5 ± 99.7 0.20 0.17 >0.99 0.032 
IL-1β 3.1 ± 10.1 2.5 ± 3.0 7.8 ± 12.9 >0.99 0.17 0.72 0.303 
IL-4 20.5 ± 5.8 31.2 ± 17.4 52.9 ± 50.6 0.008 <0.001 0.52 0.005 
IL-6 85 ± 399 956 ± 1371 1915 ± 3536 <0.001 <0.001 >0.99 <0.001 
IL-8 46.4 ± 146 80.7 ± 115.6 83.4 ± 96.5 0.005 0.012 >0.99 0.002 
IL-10 1.9 ± 0.7 3.6 ±2.2 14.7 ± 33.5 <0.001 0.004 >0.99 <0.001 
IL-12p70 6.4 ± 0.9 10.9 ± 6.6 15.3 ± 12.9 0.003 <0.001 >0.99 0.001 
IL-13 7.1 ± 1.4 9.7 ± 4.7 9.8 ± 5.1 0.045 0.018 >0.99 0.007 
IL-17A 4.0 ±2.1 8.3 ± 10.7 11.8 ± 10.3 0.014 <0.001 0.39 0.001 
MIP-1α 9.4 ± 2.5 14.1 ± 8.1 16.8 ± 21.7 0.54 >0.99 0.63 0.047 
MIP-1β 345 ± 116 298.2 ±283.7 389 ± 626 0.55 0.44 >0.99 0.237 
MCP-1 592 ± 485 705.1 ± 668.3 1283 ± 830 0.39 <0.001 0.01 <0.001 
TNF-α 76.4 ± 31.2 162 ± 178 114 ± 99 0.006 0.51 0.39 0.001 
IFN-α 4.1 ± 0.7 5.3 ± 3.2 5.3 ± 4.2 0.51 0.91 >0.99 0.141 
IFN -γ 55.6 ± 11.9 74.8 ± 47.7 132 ± 122 0.47 <0.001 0.02 <0.001 
E-Selectin 2149 ± 264 3737 ± 2287 4836 ± 5070 <0.001 <0.001 >0.99 <0.001 
P-Selectin 3724 ± 753 8679 ± 7737 13556 ± 17279 <0.001 <0.001 0.28 <0.001 
sICAM-1 2027 ± 2585 3375 ± 2659 6920 ± 6596 0.046 <0.001 0.13 <0.001 
IP10 257 ± 514 174 ± 142 380 ± 458 0.85 0.25 >0.99 0.192 
Mean ± SD                             Protein:(mg/ml), Cytokines:(pg/ml) 
†Mann-Whitney U test, compared ECD ≥ 1200 group to control group. 
‡Mann-Whitney U test, compared ECD < 1200 group to control group. 
¶Mann-Whitney U test, compared ECD < 1200 group to ECD ≥ 1200 group. 
*Trends test  
ECD: endothelial cell density, IL: interleukin, MIP: macrophage inflammatory protein, MCP: 
monocyte chemotactic protein, TNF: tumor necrosis factor, GM-CSF: granulocyte-macrophage 
colony-stimulating factor, IFN: interferon, sICAM: soluble intracellular adhesion molecule, IP10: 
interferon gamma-induced protein 10 
  
Supplementary table 3. Preoperative aqueous protein and cytokine levels stratified 
by endothelial cell density of 1,000 and 2,000 cells/mm2 at 12 months after 
Descemet’s automated stripping endothelial keratoplasty. 
Mean (SD)                                     Protein:(mg/ml), Cytokines:(pg/ml) 
†Mann-Whitney U test, compared ECD > 2000 group to control group. 
‡Mann-Whitney U test, compared 1000 < ECD < 2000 group to control group. 
¶Mann-Whitney U test, compared ECD < 1000 group to control group. 
§Mann-Whitney U test, compared ECD > 2000 group to 1000 < ECD < 2000 group 
*Mann-Whitney U test, compared ECD > 2000 group to ECD < 1000 group 
#Mann-Whitney U test, compared 1000 < ECD < 2000 group to ECD < 1000 group,  
*trends test 
ECD: endothelial cell density, IL: interleukin, MIP: macrophage inflammatory protein, MCP: 
monocyte chemotactic protein, TNF: tumor necrosis factor, IFN: interferon, sICAM: soluble 
intracellular adhesion molecule, IP10: interferon gamma-induced protein 10 
Aqueous 
cytokine 
Control 
N=33 
ECD ≥2000 
N=9 
1000 ≤ ECD < 2000 
N=34 
ECD < 1000 
N=21 
P value† P value‡ P value¶ P value§ P value* P value# P value* 
Protein 0.31 (0.23) 0.91 (0.72) 1.08 (0.88) 1.34 (0.78) － － － － － － <0.001 
IL-1α 49.3 (25.5) 80.4 (30.7) 72.3 (51.5) 108.4 (118.2) 0.13 0.25 >0.99 >0.99 0.98 >0.99 0.243 
IL-1β 3.1 (10.1) 3.7 (4.5) 3.3 (6.1) 8.91 (13.9) >0.99 >0.99 0.132 >0.99 >0.99 0.55 0.091 
IL-4 20.5 (5.8) 38.7 (18.7) 31.2 (17.3) 61.7 (57.4) 0.019 0.011 <0.001 >0.99 >0.99 0.97 <0.001 
IL-6 6.4 (0.9) 673 (942) 1170 (1676) 2318 (3996) 0.001 <0.001 <0.001  >0.99 >0.99 >0.99 <0.001 
IL-8 19.3 (1.2) 61.4 (82.5) 93.0 (127.9) 85.9 (87.8) 0.63 0.001 0.008 >0.99 >0.99 >0.99 <0.001 
IL-10 1.9 (0.7) 3.7 (1.6) 4.5 (4.2) 18.2 (39.1) 0.02 <0.001 0.02 >0.99 >0.99 >0.99 <0.001 
IL-12p70 6.4 (0.9) 12.1 (7.3) 10.0 (6.12) 18.2 (14.1) 0.09 0.04 <0.001 >0.99 >0.99 0.13 <0.001 
IL-13 7.1 (1.4) 10.1 (2.6) 9.6 (4.8) 10.3 (5.9) 0.17 0.099 0.067 >0.99 >0.99 >0.99 0.004 
IL-17A 4.0 (2.1) 6.9 (5.3) 8.4 (10.5) 14.3 (11.4) 0.82 0.009 <0.001 >0.99 0.57 0.64 <0.001 
MIP-1α 9.4 (2.5) 15.5 (10.2) 13.1 (7.3) 19.1 (25.2) >0.99 0.627 >0.99 >0.99 >0.99 >0.99 0.366 
MIP-1β 345 (116) 353 (297) 323 (286) 400 (721) >0.99 >0.99 0.35 >0.99 >0.99 >0.99 0.058 
MCP-1 449 (24) 950 (1182) 734 (581) 1387 (777) >0.99 0.79 <0.001 >0.99 0.26 0.004 <0.001 
TNF-α 76.4 (31.2) 163 (122) 153 (169) 120 (122) 0.69 0.006 >0.99 >0.99 >0.99 0.36 0.050 
IFN-α 4.1 (0.7) 5.2 (3.3) 5.1 (3.0) 5.7 (4.8) 0.63 >0.99 >0.99 >0.99 >0.99 >0.99 0.318 
IFN -γ 55.6 (11.9) 91.0 (48.4) 69.0 (42.7) 156 (136) 0.14 >0.99 <0.001 0.51 >0.99 <0.001 <0.001 
E-Selectin 2149 (264) 4964 (2858) 3353 (1988) 5456 (5588) <0.001 <0.001 <0.001 0.67 >0.99 0.27 <0.001 
P-Selectin 3724 (752) 11368 (10917) 10328 (14918) 11469 (11088) 0.047 <0.001 <0.001 >0.99 >0.99 0.61 <0.001 
sICAM-1 2027(2585) 4276 (3248) 3729 (4134) 7761 (6427) 0.13 0.15 <0.001 >0.99 >0.99 0.06 <0.001 
IP10 257 (514) 158 (152) 252 (323) 341 (410) >0.99 0.91 0.77 >0.99 >0.99 >0.99 0.168 
Supplementary table 4. Correlation between preoperative cytokine levels and 
percentage of endothelial cell density loss. 
*Spearman’s correlation analysis 
IL: interleukin, MIP: macrophage inflammatory protein, MCP: monocyte chemotactic protein, TNF: 
tumor necrosis factor, IFN: interferon, sICAM: soluble intracellular adhesion molecule, IP10: 
interferon gamma-induced protein 10 
 
  
 
%ECD loss at 6 months %ECD loss at 12months 
r P value 95% CI r P value 95% CI 
Protein 0.293 0.053 0.087 to 0.636 0.320 0.041 0.005 to 0.578 
IL-1α -0.270 0.066 -0.428 to 0.187 -0.148 0.321 -0.202 to 0.407 
IL-1β 0.058 0.706 -0.240 to 0.389 -0.027 0.858 -0.162 to 0.440 
IL-4 0.093 0.481 -0.259 to 0.287 0.289 0.031 0.021 to 0.519 
IL-6 -0.007 0.961 -0.350 to 0.192 0.047 0.727 -0.131 to 0.404 
IL-8 0.021 0.874 -0.312 to 0.233 0.085 0.528 -0.216 to 0.328 
IL-10 -0.069 0.602 -0.312 to 0.233 0.039 0.775 0.028 to 0.529 
IL-12p70 0.103 0.446 -0.229 to 0.331 0.272 0.047 -0.003 to 0.444 
IL-13 0.060 0.720 -0.270 to 0.411 0.070 0.680 -0.257 to 0.424 
IL-17A 0.355 0.021 0.049 to 0.601 0.380 0.013 0.087 to 0.619 
MIP-1α -0.289 0.067 -0.507 to 0.132 -0.198 0.215 -0.245 to 0.407 
MIP-1β -0.250 0.063 -0.446 to 0.103 -0.141 0.309 -0.249 to 0.318 
MCP-1 0.303 0.022 0.038 to 0.528 0.470 0.0002 0.232 to 0.656 
TNF-α -0.178 0.260 -0.411 to 0.241 -0.155 0.328 -0.490 to 0.136 
IFN-α 0.358 0.158 -0.440 to 0.227 0.404 0.109 -0.308 to 0.358 
IFN -γ 0.218 0.049 -0.007 to 0.495 0.392 0.0026 0.139 to 0.597 
E-Selectin 0.286 0.039 0.006 to 0.524 0.293 0.0352 0.0133 to 0.530 
P-Selectin 0.093 0.482 -0.201 to 0.333 0.050 0.710 -0.249 to 0.297 
sICAM-1 0.291 0.028 0.06 to 0.519 0.355 0.0068 0.096 to 0.569 
IP10 -0.075 0.570 -0.302 to 0.243 -0.023 0.862 -0.059 to 0.462 
Supplementary table 5. Correlation between preoperative cytokine levels and 
endothelial cell density in eyes after cataract surgery. 
*Spearman’s correlation analysis 
IL: interleukin, MIP: macrophage inflammatory protein, MCP: monocyte chemotactic protein, TNF: 
tumor necrosis factor, IFN: interferon, sICAM: soluble intracellular adhesion molecule, IP10: 
interferon gamma-induced protein 10 
 
  
 
Cataract surgery 
%ECD loss at 6 months ECD at 6 months 
r P value* r P value* 
Protein 0.231 0.519 0.171 0.589 
IL-1α 0.200 0.557 0.100 0.766 
IL-1β 0.073 0.833 -0.137 0.677 
IL-4 0.018 0.972 -0.077 0.811 
IL-6 0.330 0.322 -0.220 0.498 
IL-8 0.169 0.619 -0.228 0.489 
IL-10 0.136 0.693 -0.018 0.967 
IL-12p70 0.245 0.468 0.109 0.755 
IL-13 0.164 0.634 0.055 0.881 
IL-17A 0.005 0.995 -0.091 0.781 
MIP-1α 0.273 -0.221 0.064 0.854 
MIP-1β 0.091 0.796 0.273 0.418 
MCP-1 0.136 0.694 0.193 0.572 
TNF-α 0.264 0.435 -0.055 0.881 
IFN-α 0.255 0.451 -0.164 0.634 
IFN -γ 0.110 0.587 0.055 0.881 
E-Selectin 0.227 0.503 0.209 0.539 
P-Selectin 0.046 0.902 0.193 0.572 
sICAM-1 0.255 0.451 0.046 0.903 
IP10 0.355 0.286 0.073 0.839 
Supplementary table 6. Multivariate analysis: history of trabeculectomy was 
associated with postoperative endothelial cell density. 
 
ECD at 3 months ECD at 6 months ECD at 12 months 
β P value β P value β P value 
Trabeculectomy -0.352 0.011 -0.287 0.028 -0.278 0.026 
Laser iridotomy 0.038 0.776 -0.230 0.076 -0.300 0.018 
Lens status -0.098 0.478 -0.100 0.445 -0.216 0.085 
Graft size 0.085 0.512 0.141 0.258 0.192 0.105 
Preop steroid use -0.062 0.650 0.046 0.731 -0.058 0.646 
Adjusted R2 0.114 0.169 0.278 
VIF = 1.14 
*† Lens status, laser iridotomy and history of trabeculectomy were dichotomized as 
categorical variables for multivariate regression analysis as follows: history of 
trabeculectomy: absence = 0, presence = 1, laser iridotomy: absence = 0, presence = 1, 
lens status: phakia = 0, pseudophakia = 1 
ECD: endothelial cell density, VIF: variance inflation factor 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary table 7. Correlation between preoperative cytokine levels and 
percentage of endothelial cell density loss in eyes excluding Fuchs’ endothelial 
corneal dystrophy. 
*Spearman’s correlation analysis 
IL: interleukin, MIP: macrophage inflammatory protein, MCP: monocyte chemotactic protein, TNF: 
tumor necrosis factor, GM-CSF: granulocyte-macrophage colony-stimulating factor, IFN: interferon, 
sICAM: soluble intracellular adhesion molecule, IP10: interferon gamma-induced protein 10 
 
  
 
%ECD loss at 6 months %ECD loss at 12months 
r P value 95% CI r P value 95% CI 
Protein 0.227 0.203 -0.136 to 0.537 0.258 0.135 -0.093 to 0.552 
IL-1α -0.303 0.092 -0.596 to 0.062 -0.207 0.274 -0.522 to 0.157 
IL-1β 0.034 0.861 -0.347 to 0.405 0.062 0.746 -0.315 to 0.422 
IL-4 0.251 0.123 -0.080 to 0.532 0.417 0.010 0.097 to 0.658 
IL-6 -0.053 0.735 -0.369 to 0.270 0.040 0.801 -0.276 to 0.348 
IL-8 -0.028 0.865 -0.345 to 0.295 0.081 0.612 -0.238 to 0.383 
IL-10 -0.064 0.696 -0.376 to 0.262 0.085 0.594 -0.234 to 0.387 
IL-12p70 0.265 0.108 -0.069 to 0.546 0.375 0.0266 0.037 to 0.636 
IL-13 0.255 0.108 -0.159 to 0.592 0.309 0.127 -0.101 to 0.629 
IL-17A 0.606 0.0008 0.282 to 0.805 0.582 0.0014 0.249 to 0.792 
MIP-1α -0.350 0.068 -0.646 to 0.038 -0.311 0.109 -0.620 to 0.082 
MIP-1β -0.288 0.075 -0.560 to 0.039 -0.108 -0.503 -0.410 to 0.216 
MCP-1 0.424 0.0079 0.122 to 0.661 0.616 <0.0001 0.360 to 0.785 
TNF-α -0.109 0.567 -0.460 to 0.272 -0.198 0.295 -0.529 to 0.196 
IFN-α -0.289 0.143 -0.611 to 0.113 -0.120 0.552 -0.487 to 0.284 
IFN -γ 0.479 0.0023 0.179 to 0.698 0.623 <0.0001 0.370 to 0.790 
E-Selectin 0.564 0.0003 0.280 to 0.758 0.585 0.0002 0.309 to 0.771 
P-Selectin 0.122 0.452 -0.206 to 0.426 0.178 0.259 -0.142 to 0.465 
sICAM-1 0.356 0.028 0.032 to 0.613 0.506 0.0012 0.213 to 0.716 
IP10 -0.270 0.093 -0.543 to 0.053 -0.127 0.423 -0.423 to 0.193 
Supplementary table 7. Preoperative demographics of DSAEK patients.  
 Solitary 
DSAEK 
Combined 
DSAEK# 
P value 
Eyes (n) 43 21 - 
Sex, n (%)    
Male 14 (32.6) 7 (33.3) 
0.95* 
Female 29 (67.4) 14 (66.7) 
Age (y)  74.8 ± 9.5 73.1 ± 9.1 0.38 
BCVA (logMAR)   1.37 ± 0.60 1.13 ± 0.96 0.08 
IOP (mmHg)  13.1 ± 4.2 10.8 ± 3.4 0.01 
Axial length (mm)  23.75 ± 2.33 23.40 ± 1.52 0.76 
ECD (cells/mm2) NA NA - 
CCT (μm)  754 ± 122 716 ± 84 0.26 
DM, n (%)  6 (14) 4 (19) 0.59* 
Presence of glaucoma, n (%) 14 (33) 3 (14) 0.12* 
Number of Previous intraocular surgeries (n) 2.0 ± 1.5 0.5 ± 0.8 <0.001 
Mean ± SD 
DSAEK: Descemet’s automated stripping endothelial keratoplasty, SD: standard deviation, 
BCVA: best-corrected visual acuity, logMAR: logarithm of minimal angle resolution, IOP: 
intraocular pressure, AL: axial length, ECD: endothelial cell density, CCT: central corneal 
thickness, DM: Diabetes mellitus, IOL: intraocular lens, NA: not available  
*: Chi-square test 
#: DSAEK combined with cataract surgery 
 
